Crispr Therapeutics AG is a pioneering biotechnology company specializing in gene editing. Its primary function is to advance the development and application of CRISPR/Cas9 technology, which allows fo... Crispr Therapeutics AG is a pioneering biotechnology company specializing in gene editing. Its primary function is to advance the development and application of CRISPR/Cas9 technology, which allows for precise, directed changes to genomic DNA. The company's work focuses on harnessing this revolutionary tool to potentially treat a range of genetic diseases, including blood disorders, certain cancers, and conditions related to the immune system. Crispr Therapeutics is at the forefront of the biopharmaceutical industry, fundamentally altering how genetic disorders might be cured or managed. By collaborating with various academic and industry leaders, the company strives to bring innovative therapies from the research phase to clinical trials and, eventually, to patients in need. As a part of the broader biotechnology sector, Crispr Therapeutics plays a crucial role in the advancement of personalized medicine, making significant strides in the potential to significantly alter disease outcomes and improve patient health globally.Show lessShow more

Disclosures ESG Data Financial Data

Income Statement Balance Sheet Group Entities

Data not available

Group Entities data not yet covered for CRISPR Therapeutics

We have not yet reviewed CRISPR Therapeutics's disclosures for Group Entities data.

If this data is relevant to your work, you can submit a data coverage request and our team will investigate the company's disclosures and capture the data if available.

Would you like us to review CRISPR Therapeutics's data?

Start your 30-day free trial to request a data review for CRISPR Therapeutics.

Start Free Trial

Legal Center Contact Us